Issue

Vol. 66 No. 5: Issue 5

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Comprehensive multi-factor analysis and exploration for the pathogenesis of non-ischemic cardiomyopathy and ischemic cardiomyopathy

https://doi.org/10.14715/cmb/2020.66.5.13
Fengling Li
Department of Cardiology, Shan Xian Central Hospital, Shandong 274300, China
Lin Cheng
Department of Cardiology, Shan Xian Central Hospital, Shandong 274300, China
Lin Ma
Department of Cardiology, Shan Xian Central Hospital, Shandong 274300, China

Corresponding Author(s) : Lin Ma

2003malin@163.com

Cellular and Molecular Biology, Vol. 66 No. 5: Issue 5

Abstract

Cardiomyopathy is a group of heterogeneous diseases that negatively affect cardiac function. Twenty-five years ago, clinical researchers began to realize that cardiomyopathy is an important and fairly common heart disease. Although many aspects of the pathogenesis of cardiomyopathy have been explored by biologists, the molecular mechanisms remain elusive. This study modularized the pathogenesis of non-ischemic cardiomyopathy and ischemic cardiomyopathy and finally explored their common core pathogenic driver genes. First, based on the normal expression profile data of patients with non-ischemic cardiomyopathy and ischemic cardiomyopathy, differential expression analysis was used to screen differentially expressed genes. Secondly, the co-expression analysis of differentially expressed genes was performed to obtain a co-expression module of genes. Thirdly, the enrichment analysis of GO functions and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was conducted on the module genes. Finally, based on hypergeometric tests, non-coding RNA (ncRNA) and transcription factors with significant regulatory effects were predicted. In summary, we obtained 8 co-expression modules, of which HN1, PRDX3 genes had significant differences in expression in patients with cardiomyopathy, and had a positive regulatory role in the dysfunction module, so they were recognized as non-ischemic and key genes for non-ischemic diseases and ischemic cardiomyopathy. The enrichment results showed that the module genes were significant in the biological processes of neutrophil activation involved in immunoreaction, neutrophil-mediated immunity, neutrophil activation, and neutrophil degranulation, and significantly regulate the signal pathways such as vibrio cholerae infection. Finally, significant regulatory dysfunction modules of pivot ncRNAs (including MALAT1, miR-133a-3p, and miR-133b) and pivot TFs (including NFKB1, PML, and RELA, etc.) were identified. In summary, our work decodes a co-expression network involving the regulation of key genes in non-ischemic and ischemic cardiomyopathy. It helps to discover core dysfunction modules and potential regulatory factors, drive disease genes, and improve our understanding of its pathogenesis.

Keywords

Cardiomyopathy Co-expression module Driver gene Enrichment analysis Regulatory factors
Li, F., Cheng, L., & Ma, L. (2020). Comprehensive multi-factor analysis and exploration for the pathogenesis of non-ischemic cardiomyopathy and ischemic cardiomyopathy. Cellular and Molecular Biology, 66(5), 66–72. https://doi.org/10.14715/cmb/2020.66.5.13
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Senes M, Erbay AR, Yilmaz FM, Topkaya BC, Zengi O, Dogan M, Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy. Clinical chemistry and laboratory medicine. 2008;46(3):382-6.
  2. McKenna WJ, Maron BJ, Thiene G. Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circulation research. 2017;121(7):722-30.
  3. Mukherjee D, Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. The Journal of clinical investigation. 1991;88(4):1141-6.
  4. Finsterer J, Stollberger C, Wahbi K. Cardiomyopathy in neurological disorders. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology. 2013;22(5):389-400.
  5. Friedrich FW, Carrier L. Genetics of hypertrophic and dilated cardiomyopathy. Current pharmaceutical biotechnology. 2012;13(13):2467-76.
  6. Sawhney V, Brouilette S, Campbell N, Coppen S, Baker V, Hunter R, Association of genetic variation in telomere-related SNP and telomerase with ventricular arrhythmias in ischemic cardiomyopathy. Pacing and clinical electrophysiology: PACE. 2018;41(3):261-6.
  7. Lu YW, Wang DZ. Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy. Current cardiology reports. 2018;20(11):115.
  8. Huang ZP, Ding Y, Chen J, Wu G, Kataoka M, Hu Y, Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy. Cardiovascular research. 2016;112(2):543-54.
  9. Li X, Liu CY, Li YS, Xu J, Li DG, Li X, Deep RNA sequencing elucidates microRNA-regulated molecular pathways in ischemic cardiomyopathy and nonischemic cardiomyopathy. Genetics and molecular research: GMR. 2016;15(2).
  10. Kruska M, El-Battrawy I, Behnes M, Borggrefe M, Akin I. Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death. Current pharmaceutical biotechnology. 2017;18(6):472-81.
  11. Xie MB, Sui XQ, Pei D, Yao Q, Huang Q. Study on the expression and mechanism of plasma microRNA-21 in patients with ischemic cardiomyopathy. European review for medical and pharmacological sciences. 2017;21(20):4649-53.
  12. Ermis C, Zhu AX, Vanheel L, Lemke MJ, Sakaguchi S, Lurie KG, Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators. The American journal of cardiology. 2005;96(2):233-8.
  13. Sedlacek K, Ruwald AC, Kutyifa V, McNitt S, Thomsen PEB, Klein H, The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial. Journal of cardiovascular electrophysiology. 2015;26(4):424-33.
  14. Rijnierse MT, de Haan S, Harms HJ, Robbers LF, Wu L, Danad I, Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy. Circulation Cardiovascular imaging. 2014;7(1):20-30.
  15. Bhatti S, Hakeem A, Yousuf MA, Al-Khalidi HR, Mazur W, Shizukuda Y. Diagnostic performance of computed tomography angiography for differentiating ischemic vs nonischemic cardiomyopathy. Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology. 2011;18(3):407-20.
  16. Chen HX, Huang L, Yang L, Chen YT, Huang JM. Model-based method with nonlinear ultrasonic system identification for mechanical structural health assessment. Trans Emerge Telecommun Technol 2020; 1-15.
  17. Chen X, Xu Y, Meng L, Chen X, Yuan L, Cai Q, Shi W, Huang G. Non-parametric partial least squares-discriminant analysis model based on sum of ranking difference algorithm for tea grade identification using electronic tongue data. Sens Actuators B Chem 2020; 311:127924-127931.
  18. Guo T, Lin Q, Li X, Nie Y, Wang L, Shi L, Xu W, Hu T, Guo T, Luo F. Octacosanol Attenuates Inflammation in Both RAW264.7 Macrophages and a Mouse Model of Colitis. J Agri Food Chem 2017; 65(18): 3647-3658.
  19. Jiang X, Zhu B, Chevallier J, Xie R. Allocating provincial CO2 quotas for the Chinese national carbon program. Australian J Agri Res Econ 2018; 62(3): 457-479.
  20. Li W, Jia MX, Wang JH, Lu JL, Deng J, Tang JX, Liu, C. Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese Population. Biomolecules 2019; 9(3): 107-119.
  21. Liang Y, Lin Q, Huang P, Wang Y, Li J, Zhang L, Cao J. Rice Bioactive Peptide Binding with TLR4 To Overcome H2O2-Induced Injury in Human Umbilical Vein Endothelial Cells through NF-kappa B Signaling. J Agri Food Chem 2018; 66(2): 440-448.
  22. Lou Y, Guo D, Zhang H, Song L. Effectiveness of mesenchymal stems cells cultured by hanging drop vs. conventional culturing on the repair of hypoxic-ischemic-damaged mouse brains, measured by stemness gene expression. Open Life Sci 2016; 11(1): 519-523.
  23. Lou Y, Shi J, Guo D, Qureshi AK, Song L. Function of PD-L1 in antitumor immunity of glioma cells. Saudi J Biol Sci 2017; 24(4): 803-807.
  24. Lou Y, Yang J, Wang L, Chen X, Xin X, Liu Y. The clinical efficacy study of treatment to Chiari malformation type I with syringomyelia under the minimally invasive surgery of resection of Submeningeal cerebellar Tonsillar Herniation and reconstruction of Cisterna magna. Saudi J Biol Sci 2019; 26(8): 1927-1931.
  25. Nie Y, Luo F, Lin Q. Dietary nutrition and gut microflora: A promising target for treating diseases. Trends Food Sci Technol 2018; 75: 72-80.
  26. Nie Y, Luo F, Wang L, Yang T, Shi L, Li X, Shen J, Xu W, Guo T, Lin Q. Anti-hyperlipidemic effect of rice bran polysaccharide and its potential mechanism in high-fat diet mice. Food Func 2017; 8(11): 4028-4041.
  27. Ren Y, Jiao X, Zhang L. Expression level of fibroblast growth factor 5 (FGF5) in the peripheral blood of primary hypertension and its clinical significance. Saudi J Biol Sci 2018; 25(3): 469-473.
  28. Wang L, Lin Q, Yang T, Liang Y, Nie Y, Luo Y, Shen J, Fu X, Tang Y, Luo F. Oryzanol Modifies High Fat Diet-Induced Obesity, Liver Gene Expression Profile, and Inflammation Response in Mice. J Agri Food Chem 2017; 65(38): 8374-8385.
  29. Zhang T, Wu X, Shaheen SM, Zhao Q, Liu X, Rinklebe J, Ren H. Ammonium nitrogen recovery from digestate by hydrothermal pretreatment followed by activated hydrochar sorption. Chem Eng J 2020; 379: 1-54.
  30. Zhu B, Pang R, Chevallier J, Wei YM, Vo DT. Including intangible costs into the cost-of-illness approach: a method refinement illustrated based on the PM2.5 economic burden in China. Europ J Health Econ 2019; 20(4): 501-511.
  31. Chen H, Chen Y, Yang L. Intelligent early structural health prognosis with nonlinear system identification for RFID signal analysis. Comput Commun 2020; 157: 150-161.
  32. Yang M, Abdalrahman H, Sonia U, Mohammed A, Vestine U, Wang M, Ebadi AG, Toughani M. The application of DNA molecular markers in the study of Codonopsis species genetic variation, a review. Cell Mol Biol 2020; 2: 23-30.
  33. He L, Fang H, Wang X, Wang Y, Ge H, Li C, Chen C, Wan Y, He H. The 100 most-cited articles in urological surgery: A bibliometric analysis. Int J Surg 2020; 75: 74-79.
  34. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, NCBI GEO: archive for functional genomics data sets--update. Nucleic acids research. 2013;41(Database issue): D991-5.
  35. Yi, Y., RAID v2.0: an updated resource of RNA-associated interactions across organisms. Nucleic Acids Res, 2017. 45(D1): p. D115-D118.
  36. Cappuzzello C, Napolitano M, Arcelli D, Melillo G, Melchionna R, Di Vito L, Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiological genomics. 2009;38(3):233-40.
  37. Han, H., TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res, 2018. 46(D1): p. D380-D386.
  38. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008; 9:559.
  39. Yu, G, Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS, 2012. 16(5): p. 284-7.
  40. Maere, S., K. Heymans, and M. Kuiper, BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics, 2005. 21(16): p. 3448-9.
  41. Zhao TT, Wasti B, Xu DY, Shen L, Du JQ, Zhao SP. Soluble epoxide hydrolase and ischemic cardiomyopathy. International journal of cardiology. 2012;155(2):181-7.
  42. Yoruk U, Yaykasli KO, Ozhan H, Aslantas Y, Karabacak A, Basar C, Kaya E, Bulur S, Memisogulları R. Association of omentin Val109Asp polymorphism with coronary artery disease, Anatol J Cardiol 2014; 14(6):511-514.
  43. De Bonis M, Lapenna E, Ficarra E, La Canna G, Verzini A, Pagliaro M, Surgical options in ischemic cardiomyopathy. Italian heart journal: official journal of the Italian Federation of Cardiology. 2004;5 Suppl 6:100S-7S.
  44. Lindsey M, Wedin K, Brown MD, Keller C, Evans AJ, Smolen J, Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation. 2001;103(17):2181-7.
  45. Cash JL, Bena S, Headland SE, McArthur S, Brancaleone V, Perretti M. Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23. EMBO reports. 2013;14(11):999-1007.
  46. Dhote-Burger P, Vuilleminot A, Lecompte T, Pasquier C, Bara L, Julia P, Neutrophil degranulation related to the reperfusion of ischemic human heart during cardiopulmonary bypass. Journal of cardiovascular pharmacology. 1995;25 Suppl 2:S124-9.
  47. Saha P, Katarkar A, Das B, Bhattacharyya A, Chaudhuri K. 6-Gingerol inhibits Vibrio cholerae-induced proinflammatory cytokines in intestinal epithelial cells via modulation of NF-kappaB. Pharmaceutical biology. 2016;54(9):1606-15.
  48. Zhang C, Xu B, Lu S, Zhao Y, Liu P. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity. Molecular cancer. 2017;16(1):90.
  49. Rosello-Lleti E, Tarazon E, Barderas MG, Ortega A, Molina-Navarro MM, Martinez A, ATP synthase subunit alpha and LV mass in ischaemic human hearts. Journal of cellular and molecular medicine. 2015;19(2):442-51.
  50. Adra CN, Iyengar AR, Syed FA, Kanaan IN, Rilo HL, Yu W, Human ARHGDIG, a GDP-dissociation inhibitor for Rho proteins: genomic structure, sequence, expression analysis, and mapping to chromosome 16p13.3. Genomics. 1998;53(1):104-9.
  51. Scrivens PJ, Shahrzad N, Moores A, Morin A, Brunet S, Sacher M. TRAPPC2L is a novel, highly conserved TRAPP-interacting protein. Traffic. 2009;10(6):724-36.
  52. Jiang L, Zhou J, Zhong D, Zhou Y, Zhang W, Wu W, Overexpression of SMC4 activates TGFbeta/Smad signaling and promotes aggressive phenotype in glioma cells. Oncogenesis. 2017;6(3):e301.
  53. Zhao ZH, Hao W, Meng QT, Du XB, Lei SQ, Xia ZY. Long non-coding RNA MALAT1 functions as a mediator in cardioprotective effects of fentanyl in myocardial ischemia-reperfusion injury. Cell biology international. 2017;41(1):62-70.
  54. Yin Y, Du L, Li X, Zhang X, Gao Y. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma. Journal of cellular physiology. 2018.
  55. Zhang Y, Sun L, Sun H, Liu X, Luo X, Li C, Overexpression of microRNA-133b reduces myocardial injuries in children with viral myocarditis by targeting Rab27B gene. Cellular and molecular biology. 2017;63(10):80-6.
  56. Krell A, Wolter M, Stojcheva N, Hertler C, Liesenberg F, Zapatka M, MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis, and response to cytotoxic therapy. Neuropathology and applied neurobiology. 2018.
  57. Fan S, Yang Z, Ke Z, Huang K, Liu N, Fang X, Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer. Biomedicine & pharmacotherapy = Biomedicine & pharmacotherapie. 2017;95:1636-43.
  58. Zhou B, Rao L, Peng Y, Wang Y, Li Y, Gao L, Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy. BMC medical genetics. 2009; 10:47.
  59. Santos DG, Resende MF, Mill JG, Mansur AJ, Krieger JE, Pereira AC. Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure. BMC medical genetics. 2010;11:89.
  60. Wang YT, Chen RH. PML degradation fosters an immunosuppressive and pro-metastatic tumor microenvironment. Molecular & cellular oncology. 2017;4(6):e1364212.
  61. Hatipoglu OF, Yaykasli KO, Dogan M, Yaykasli E, Bender O, Yasar T, Tapan S, Gunduz M. NF-κB and MAPKs are involved in resistin caused ADAMTS-5 induction in Human Chondrocytes. Clin Invest Med 2015; 38(4): E248-E254.
  62. Bordbar M, Darvishzadeh R, Pazhouhandeh M, Kahrizi D. An overview of genome editing methods based on endonucleases. Modern Genetics J 2020; 15(2): 75-92.
  63. Wang X, Tao Y, Huang Y, Zhan K, Xue M, Wang Y, Catalase ameliorates diabetes-induced cardiac injury through reduced p65/RelA- mediated transcription of BECN1. Journal of cellular and molecular medicine. 2017;21(12):3420-34.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 942 Download : 507